Fortrea Holdings (FTRE) Shares Outstanding (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Shares Outstanding (Entity) came in at $95.1 million in Q2 2026, up 4.74% YoY from $90.8 million in Q2 2025, and up 0.53% on a QoQ basis from $94.6 million in Q1 2026.
Fortrea Holdings (FTRE) Shares Outstanding (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has 5 years of Shares Outstanding (Entity) data on file, last reported at $95.1 million in Q2 2026.
- Quarterly Shares Outstanding (Entity) rose 4.74% year-over-year to $95.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $95.1 million (up 4.74% YoY) and the FY2025 annual result came in at $93.1 million, up 3.79% from the prior year.
- Shares Outstanding (Entity) climbed to $95.1 million in Q2 2026, from $94.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $95.1 million in Q2 2026 to a low of $88.8 million in Q2 2022.
- A 5-year average of $90.4 million and a median of $89.5 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) changed 0.0% — and 2026, when it grew 4.74%.
- Tracing FTRE's Shares Outstanding (Entity) over 5 years: stood at $88.8 million in 2022, then changed by 0.0% to $88.8 million in 2023, then gained by 1.01% to $89.7 million in 2024, then gained by 3.79% to $93.1 million in 2025, then advanced by 2.15% to $95.1 million in 2026.
- The last three Shares Outstanding (Entity) figures came in at $95.1 million (Q2 2026), $94.6 million (Q1 2026), and $93.1 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Fortrea Holdings | 1.66 Bn | 1.49 Bn | 139.20 Mn | 94.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 94.80 Mn |
| Mar 31, 2026 | 93.60 Mn |
| Dec 31, 2025 | 91.20 Mn |
| Sep 30, 2025 | 91.20 Mn |
| Jun 30, 2025 | 90.60 Mn |
| Mar 31, 2025 | 90.10 Mn |
| Dec 31, 2024 | 89.50 Mn |
| Sep 30, 2024 | 89.60 Mn |
| Jun 30, 2024 | 89.40 Mn |
| Mar 31, 2024 | 89.20 Mn |
| Dec 31, 2023 | 88.80 Mn |
| Sep 30, 2023 | 88.80 Mn |
| Jun 30, 2023 | 88.80 Mn |
| Mar 31, 2023 | 88.80 Mn |
| Dec 31, 2022 | 88.80 Mn |
| Sep 30, 2022 | 88.80 Mn |
| Jun 30, 2022 | 88.80 Mn |